Clemastinefumarate CAS 14976-57-9

CAS:14976-57-9
Melting point  158-162°C
MF: C25H30ClNO5
Other Names:141761-83-3 1222-05-5 79673-53-3

CAS: 14976-57-9
MF: C25H30ClNO5
Purity: 99%
Clemastinefumarate CAS 14976-57-9
Fill out this field
请输入有效的电子邮箱地址。
Fill out this field
Fill out this field
Fill out this field
You need to agree with the terms to proceed

What is of  Clemastinefumarate with CAS 14976-57-9?

The fumaric acid salt of clemastine. An antihistamine with antimuscarinic and moderate sedative properties, it is used for the symptomatic relief of allergic conditions such as rhinitis, urticaria, conjunctivitis and in pruritic (severe itching) skin condi ions.

Description

Product Name: Clemastine fumarate
Synonyms: CLEMASTINE FUMARATE;CLEMASTINE FUMARATE SALT;(+)-2-(2-((p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrro;(+)-2-(2-((p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrroli;(+)-lfumarate(1:1);1-methyl-2-(2-(methyl-p-chlorodiphenylmethyloxy)ethyl)pyrrolidine;(2R)-2-[2-[(1R)-1-(4-CHLOROPHENYLETHOXY)]ETHYL]-1-METHYL-2-PYRROLIDINE FUMARATE;2-(2-(1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine
CAS: 14976-57-9
MF: C25H30ClNO5
MW: 459.96
EINECS: 239-055-2
Product Categories: antianaphylaxis;TAVIST;Histaminergics;Antagonists;Neurotransmitters;Aromatics;Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals
Mol File: 14976-57-9.mol

Application

Clemastine fumarate is a selective histamine H1 receptor antagonist (Ki = 0.26 nM) that also displays high affinity for muscarinic receptors (Ki = 16 nM). It has also recently been identified as a positive allosteric modulator of P2X7 receptor signaling. Clemastine fumarate has long been used to inhibit histamine-induced bronchoconstriction in asthma and airway hyperresponsive studies.

Packing

25kgs/drum,9tons/20’container,25kgs/bag,20tons/20’container.

Potassium nonafluoro 1 butanesulfonate package

Clemastinefumarate CAS 14976-57-9
Fill out this field
请输入有效的电子邮箱地址。
Fill out this field
Fill out this field
Fill out this field
You need to agree with the terms to proceed

You may also like